TRCT
BCDA icon

Tower Research Capital (TRC)’s BioCardia BCDA Stock Holding History

Tower Research Capital (TRC)’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95K Buy
3,187
+209
+7% +$220 ﹤0.01% 4448
2026
Q1 		$3.6K Sell
2,978
-316
-10% -$395 ﹤0.01% 4292
2025
Q4 		$4.12K Buy
3,294
+3,197
+3,296% +$4.34K ﹤0.01% 4257
2025
Q3 		$125 Buy
+97
New +$189 ﹤0.01% 5096
2025
Q1 		– Sell
-535
Closed -$1.17K – 5196
2024
Q4 		$1.17K Sell
535
-747
-58% -$1.75K ﹤0.01% 5075
2024
Q3 		$4K Sell
1,282
-1,754
-58% -$5.05K ﹤0.01% 4711
2024
Q2 		$9.02K Buy
3,036
+3,015
+14,357% +$15.1K ﹤0.01% 4298
2024
Q1 		$127 Buy
21
+5
+31% +$36 ﹤0.01% 5624
2023
Q4 		$159 Buy
+16
New +$130 ﹤0.01% 5663
2023
Q3 		– Sell
-10
Closed -$382 – 5946
2023
Q2 		$382 Sell
10
-130
-93% -$4.01K ﹤0.01% 5666
2023
Q1 		$4K Buy
140
+67
+92% +$2.22K ﹤0.01% 5046
2022
Q4 		$2K Sell
73
-87
-54% -$2.47K ﹤0.01% 5328
2022
Q3 		$5K Buy
160
+109
+214% +$2.82K ﹤0.01% 5124
2022
Q2 		$1K Buy
+51
New +$1.22K ﹤0.01% 5733
2022
Q1 		– Sell
-147
Closed -$4K – 6084
2021
Q4 		$4K Buy
+147
New +$5.39K ﹤0.01% 5278
2021
Q2 		– Sell
-213
Closed -$14K – 5464
2021
Q1 		$14K Sell
213
-455
-68% -$28.4K ﹤0.01% 4143
2020
Q4 		$35K Buy
+668
New +$26.7K ﹤0.01% 3444
2020
Q3 		– Sell
-173
Closed -$6K – 4815
2020
Q2 		$6K Buy
+173
New +$9.37K ﹤0.01% 4198
2020
Q1 		– Sell
-154
Closed -$8K – 3050
2019
Q4 		$8K Buy
154
+21
+16% +$1.23K ﹤0.01% 2429
2019
Q3 		$7K Buy
+133
New +$9.54K ﹤0.01% 3125

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Tower Research Capital (TRC)'s BCDA Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its BioCardia (BCDA) stake by 7% in Q2 2026, buying an estimated $220 and bringing the position to 3,187 shares worth $3.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4448.

Tower Research Capital (TRC) first reported a position in BCDA in Q3 2019 and has held it in 20 quarters since. The position peaked at $35K in Q4 2020. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • Tower Research Capital (TRC) held 3,187 shares of BioCardia worth $3.95K as of Q2 2026.
  • Tower Research Capital (TRC) bought 209 BioCardia shares in Q2 2026, an estimated $220.
  • BioCardia made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4448 holding.
  • Tower Research Capital (TRC) first reported a position in BioCardia in Q3 2019 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s BioCardia position peaked at $35K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.